Author:
Phillips J. L.,Wassersug R. J.,McLeod D. L.
Reference57 articles.
1. Androgen-deprivation therapy in prostate cancer: a European expert panel review;Schulman;Eur Urol Suppl,2010
2. Letter to the editor re: Schulman C, Irani J, Morote J et al. Androgen-deprivation therapy in prostate cancer: a European expert panel review;Langley;Eur Urol,2011
3. Androgen deprivation therapy for prostate cancer: new concepts and concerns;Smith;Curr Opin Endocrinol Diabetes Obes,2007
4. Adverse effects of androgen deprivation therapy in prostate cancer: current management issues;Bagrodia;Indian J Urol,2009
5. United States of America Food and Drug Administration GnRH agonists: label change increased risk of diabetes and cardiovascular disease (update) 2010 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230359.htm
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献